rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Peng Lu

President

Company insider

Files Form 4 as: President, Pharvaris.

Every Form 4 they filed

In numbers

Trades disclosed
98
Buys
0
Sells
11
Bought
$0
Sold
$13.9M
Companies
1
Companies where not an officer
0
First trade
16 Apr 2026
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
PHVS PharvarisOfficer · Biotechnology · last 12 Oct 20260 buys · 11 sells

Activity over time

1 Apr – 1 Oct
50Apr 26Jun 26Jul 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026PHVS PharvarisBiotechnologySEC FORM 4 Code F$3,639117 at $31.10filing
11 Oct 2026filed 13 Oct 2026PHVS PharvarisBiotechnologySEC FORM 4 Code F$3,390109 at $31.10filing
22 Sep 2026filed 24 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$117K45,308 at $2.59filing
22 Sep 2026filed 24 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—45,308 at $0.00filing
22 Sep 2026filed 24 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—45,308 at $0.00filing
22 Sep 2026filed 24 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$117K45,308 at $2.59filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$259K100,000 at $2.59filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$3.5M100,000 at $35.00filing
17 Sep 2026filed 21 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—13,308 at $0.00filing
17 Sep 2026filed 21 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—13,308 at $0.00filing
17 Sep 2026filed 21 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—86,692 at $0.00filing
17 Sep 2026filed 21 Sep 2026PHVS Pharvarisoption or derivative · BiotechnologySEC FORM 4 Code M—86,692 at $0.00filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$259K100,000 at $2.59filing
17 Sep 2026filed 21 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$3.5M100,000 at $35.00filing
14 Sep 2026filed 15 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code F$4,448117 at $38.02filing
14 Sep 2026filed 15 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code F$4,448117 at $38.02filing
11 Sep 2026filed 15 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$39K15,000 at $2.59filing
11 Sep 2026filed 15 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Sold$602K15,000 at $40.13filing
11 Sep 2026filed 15 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code F$4,089109 at $37.51filing
11 Sep 2026filed 15 Sep 2026PHVS PharvarisBiotechnologySEC FORM 4 Code M$39K15,000 at $2.59filing

News

Pharvaris (NASDAQ:PHVS) President Peng Lu Sells 100,000 Sharesdailypolitical.com · 21 Sep 2026

1 headline in the last 90 days name Peng Lu; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care11

Buys in green, sells in red, by the company’s sector.

Related people

Viviane MongesDirector · Director at Pharvaris, filing Form 4 there in the last year
Johannes Gerardus Christiaan Petrus SchikanDirector · Director at Pharvaris, filing Form 4 there in the last year
David W. NassifCFO / CLO · CFO / CLO at Pharvaris, filing Form 4 there in the last year
Anne LesageChief Early Development · Chief Early Development at Pharvaris, filing Form 4 there in the last year
Robert GlassmanDirector · Director at Pharvaris, filing Form 4 there in the last year
Elisabeth BjorkDirector · Also traded PHVS in the last 90 days
Stefan Andreas AbeleChief Technical Ops Officer · Also traded PHVS in the last 90 days
Wim SouverijnsChief Commercial Officer · Also traded PHVS in the last 90 days